BDX Stock: Becton, Dickinson and Company Stock Price, Analysis & Insights
Get live BDX stock price $150.66, comprehensive Becton, Dickinson and Company stock analysis, charts, news, and expert forecast. Real-time BDX stock data and investment insights.
Loading chart data...
Becton, Dickinson and Company (BDX) Overview
Becton, Dickinson and Company (BDX) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, BDX trades at $150.66 with a market capitalization of 54.58B . Over the past 52 weeks, BDX has traded between $127.59 and $187.35 , with the current price positioned at approximately 39% of this range . ...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 54.58B
- Current price: $150.66
- 52-week range: $127.59 - $187.35
- P/E ratio: 26.29
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, a...
Company Information
- CEO
- Thomas E. Polen Jr.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 70000
Contact Information
- Website
- https://www.bd.com
- Address
- 1 Becton Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 26.3)
✓ Lower volatility stock (Beta: 0.28) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Becton, Dickinson and Company shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Becton, Dickinson and Company
- ⚠Investors should consider how Becton, Dickinson and Company fits within their overall portfolio allocation
Market Cap
54.58B
P/E Ratio (TTM)
26.29
Beta
0.28
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BDX with peer companies:
- Price
- $133.66
- Market cap
- 37.75B
- Price
- $67.13
- Market cap
- 32.72B
- Price
- $880.34
- Market cap
- 54.48B
- Price
- $216.91
- Market cap
- 50.80B
- Price
- $86.48
- Market cap
- 49.80B
- Price
- $9.16
- Market cap
- 40.51B
- Price
- $568.87
- Market cap
- 44.87B
- Price
- $184.85
- Market cap
- 30.85B
- Price
- $196.50
- Market cap
- 28.50B
- Price
- $166.91
- Market cap
- 27.24B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.